0.58
+0.002(+0.35%)
Currency In GBp
Address
60 Gracechurch Street
London, EC3V 0HR
United Kingdom of Great Britain and Northern Ireland
Phone
44 1332 690061
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
5
First IPO Date
July 01, 1988
| Name | Title | Pay | Year Born |
| Mr. Nigel James Theobald | Founder, Chief Executive Officer & Executive Director | 82,500 | 1964 |
| Mr. Luke Sebastian Cairns | Executive Director | 44,000 | 1978 |
| Dr. Margaret Courtney Ph.D. | Head of Chemistry, Manufacturing & Controls | 0 | N/A |
| Dr. Andrew Leishman | Consultant | 0 | N/A |
| Dr. Fiona McLaughlin FSB, Ph.D. | Head of Research & Development | 0 | 1970 |
| Mr. Mark Edbrooke Ph.D. | Head of Strategy | 0 | N/A |
| Rob Harris | Head of CMC Development | 0 | N/A |
N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
